查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1300996

皮肤科 CRO 市场规模、份额和趋势分析报告：按类型、按服务类型、按地区、细分市场趋势，2023-2030 年

Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical Affairs), By Region (North America, Asia Pacific), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10个工作天内

价格

皮肤科 CRO 市场增长和趋势

GrandView Research, Inc. 的最新报告预测，到 2030 年，全球皮肤科 CRO 市场将达到 80.579 亿美元，预测期内復合年增长率为 6.8%。

越来越多的 CRO（合同研究组织）涌入以减少与皮肤病相关的疾病负担，这是该市场的主要驱动力。 此外，对治疗痤疮的抗感染剂、抗炎剂、局部麻醉剂、润肤剂和清洁剂等皮肤科外用药的需求不断增长，是推动市场增长的主要因素。 对快速诊断的高需求、皮肤癌和其他皮肤病患病率的增加以及对皮肤病认识的提高是推动市场增长的主要因素。

全球皮肤病病例的增加预计将在预测期内推动市场增长。 特应性皮炎是最常见的炎症性皮肤病之一，影响美国约 5-10% 的患者。 此外，皮肤癌是美国□□最常见的癌症。 根据美国皮肤病学会的数据，大约五分之一的人在一生中会患上皮肤癌。 据估计，美国每天约有 9,500 人被诊断患有皮肤癌。 COVID-19疫情对市场产生了重大影响。

包括皮肤科在内的许多治疗领域的临床试验都受到了 COVID-19 大流行的影响。 多项临床试验被暂时推迟或取消，影响了研究进度和进展。 由于皮肤科 CRO 服务与临床试验活动密切相关，这种中断预计将影响皮肤科 CRO 的增长和收入。 此外，皮肤科行业专利到期和研发项目投资增加是预计未来几年推动市场增长的主要因素。 例如，2022 年 2 月，Recipharm 收购了 CDMO Arranta Bio，以扩大其在美国的 mRNA 生物製剂产品。 此次收购预计将增强公司在癌症、牛皮癣、传染病等治疗领域的药物开发能力。

皮肤科 CRO 市场报告亮点

  • 按类型划分，临床领域将占销售额的最大份额，到 2022 年将达到 76.10%。 这是由于临床试验的全球化、技术的进步以及对皮肤科 CRO 进行临床试验的需求不断增加。
  • 按服务类型划分，监管/医疗行业预计将在预测期内占据较大的市场份额。 新产品审批需求的增加和全球製药法规的差异是该领域增长的主要驱动力。
  • 2022 年，亚太地区的收入份额将超过 43.29%，位居第一。 这部分是由于人口的多样性、皮肤病的高患病率、监管框架的改进以及患者招募和保留的便利性。
  • 新冠疫情后临床试验的激增为 CRO 进入皮肤科领域提供了利润丰厚的机会。 例如，2022年1月，Vial通过其子公司Vial Dermatology CRO推出了皮肤科外包服务。 在那里，我们与美国 35 家皮肤科诊所合作，提供更快的临床试验。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 区域范围
  • 估计/预测时间表
  • 目的
  • 调查方法
  • 信息获取
  • 信息或数据分析
  • 市场形成和验证
  • 型号详细信息
  • 辅助信息列表
  • 缩写列表

第 2 章执行摘要

  • 市场前景
  • 分部展望
  • 竞争考虑因素

第 3 章皮肤科 CRO 市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 皮肤科 CRO 市场分析工具
    • 行业分析-波特分析
    • PESTEL 分析
    • COVID-19 感染的影响分析

第 4 章皮肤科 CRO 市场：类型估计和趋势分析

  • 皮肤科 CRO 市场，按类型：细分仪表板
  • 皮肤科 CRO 市场，按类型：变异分析
    • 药物发现
    • 临床前
    • 临床

第五章皮肤科 CRO 市场：服务类型估算和趋势分析

  • 皮肤科 CRO 市场，按服务类型划分：细分仪表板
  • 皮肤科 CRO 市场，按服务类型划分：变化分析
    • 项目管理/临床供应管理
    • 数据管理
    • 监管/医疗
    • 医学写作
    • 临床监测
    • 质量控制和保证
    • 生物统计学
    • 向调查人员付款
    • 患者和设施招募
    • 实验室
    • 技术
    • 其他

第六章皮肤科CRO市场：区域估算和趋势分析

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 北美
    • 2018-2030 年市场预估和预测（收入）
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 伊朗
    • 科威特

第七章竞争格局

  • 市场进入者分类
    • 创新者
    • 市场领导者
    • 新兴玩家
    • 2022 年公司市场份额分析
  • 公司简介
    • IQVIA, Inc.
    • Labcorp Drug Development
    • Aragen Life Sciences Ltd
    • Pharmaceutical Product Development, Inc.（Thermo Fisher Scientific Inc.）
    • Parexel International Corporation
    • Charles River Laboratories
    • Icon, Plc
    • Medidata
    • Syneos Health
    • S Pharmaron
    • Wuxi Apptec
    • Medpace
    • CTI Clinical Trial &Consulting
    • Bioskin
    • Proinnovera GmbH
    • Biorasi, LLC
    • Javara
    • TFS
Product Code: GVR-4-68039-635-9

Dermatology CRO Market Growth & Trends

The global dermatology CRO market size is expected to reach USD 8,057.9 million by 2030, registering a CAGR of 6.8% over the forecast period, according to a new report by Grand View Research, Inc. Rising influx of contract research organizations (CROs) to mitigate the disease burden associated with dermatological conditions is a key driver for this market. Moreover, the rising demand for topical dermatological medications, such as anti-infective, anti-inflammatory agents, local anesthetics, emollients, and cleansers, to cure acne are major factors driving the market growth. High demand for speedy diagnosis, an increase in the prevalence of skin cancer and other skin problems, and increased awareness regarding skin diseases are major factors boosting the market growth.

An increase in cases of skin disease across the globe is expected to propel the market growth in the forecast period. Atopic dermatitis is one of the most common inflammatory skin diseases, affecting around 5-10% of individuals in the U.S. Around one in three individuals in the country with atopic dermatitis have moderate-to-severe disease. Moreover, skin cancer is the most common cancer in the U.S. According to the American Academy of Dermatology, around 1 in 5 individuals would develop skin cancer in their lifetime. In addition, it is estimated that around 9500 individuals in the country are diagnosed with skin cancer every day. The COVID-19 pandemic significantly impacted the market.

Clinical trials in numerous therapeutic fields, including dermatology, were impacted by the COVID-19 pandemic. Several clinical trials were temporarily delayed or halted, impacting the timelines and progress of research studies. This disruption is expected to affect the growth and revenue of dermatology CROs, as their services are closely tied to clinical trial activities. Furthermore, patent expiration in the dermatology industry and growing investment in R&D programs are key factors anticipated to drive market growth in the coming years. For instance, in February 2022, Recipharm acquired CDMO Arranta Bio to expand its mRNA biologics offerings in the U.S. This acquisition is expected to improve the company's capabilities in developing medications in the area of cancer, psoriasis, infectious diseases, and other diseases.

Dermatology CRO Market Report Highlights

  • Based on type, the clinical segment accounted for the largest revenue share of 76.10% in 2022. This is attributed to the globalization of clinical trials, technological advancements, and an increase in demand for dermatology CROs to conduct clinical trials
  • Based on service type, the regulatory/medical affairs segment is expected to show a significant market share in the forecast period. Increasing demand to obtain approval for new products and differences in drug regulations globally are some of the major factors driving the segment growth
  • Asia Pacific captured the largest revenue share of over 43.29% in 2022. This is due to the diversity in population, high prevalence of skin disorders, improving regulatory framework, and, the ease with which patients may be recruited and retained
  • A post-covid surge in clinical trials provided a lucrative opportunity for CROs to enter the dermatology space. For instance, in January 2022, Vial started providing dermatology outsourcing services via its arm Vial Dermatology CRO. Wherein, they partnered with 35 dermatology clinics in the U.S. to provide faster clinical trials

Table of Content

Chapter 1. Research Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Type
    • 1.1.3. Service Type
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Dermatology CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing adoption of advanced technologies
      • 3.2.1.2. Growing interest to look more appealing
      • 3.2.1.3. Increasing outsourcing of R&D activities
      • 3.2.1.4. Favorable environment for clinical trials in developing countries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Quality issues of CRO services
      • 3.2.2.2. Intellectual property rights issues
  • 3.3. Dermatology CRO Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Dermatology CRO Market: Type Estimates & Trend Analysis

  • 4.1. Dermatology CRO Market, By Type: Segment Dashboard
  • 4.2. Dermatology CRO Market, By Type: Movement Analysis
  • 4.3. Dermatology CRO Market Estimates & Forecasts, By Type, 2018 - 2030
    • 4.3.1. Drug Discovery
      • 4.3.1.1. Drug Discovery Market, 2018 to 2030 (USD Million)
      • 4.3.1.2. Target Validation
      • 4.3.1.2.1. Target Validation Market, 2018 to 2030 (USD Million)
      • 4.3.1.3. Lead Identification
      • 4.3.1.3.1. Lead Identification Market, 2018 to 2030 (USD Million)
      • 4.3.1.4. Lead Optimization
      • 4.3.1.4.1. Lead Optimization Market, 2018 to 2030 (USD Million)
    • 4.3.2. Preclinical
      • 4.3.2.1. Preclinical Market, 2018 to 2030 (USD Million)
    • 4.3.3. Clinical
      • 4.3.3.1. Clinical Market, 2018 to 2030 (USD Million)
      • 4.3.3.2. Phase I
      • 4.3.3.2.1. Phase I Market, 2018 to 2030 (USD Million)
      • 4.3.3.3. Phase II
      • 4.3.3.3.1. Phase II Market, 2018 to 2030 (USD Million)
      • 4.3.3.4. Phase III
      • 4.3.3.4.1. Phase III Market, 2018 to 2030 (USD Million)
      • 4.3.3.5. Phase IV
      • 4.3.3.5.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 5. Dermatology CRO Market: Service Type Estimates & Trend Analysis

  • 5.1. Dermatology CRO Market, By Service Type: Segment Dashboard
  • 5.2. Dermatology CRO Market, By Service Type: Movement Analysis
  • 5.3. Dermatology CRO Market Estimates & Forecasts, By Service Type, 2018 - 2030
    • 5.3.1. Project Management/Clinical Supply Management
      • 5.3.1.1. Project Management/Clinical Supply Management Market, 2018 to 2030 (USD Million)
    • 5.3.2. Data Management
      • 5.3.2.1. Data Management Market, 2018 to 2030 (USD Million)
    • 5.3.3. Regulatory/Medical Affairs
      • 5.3.3.1. Regulatory/Medical Affairs Market, 2018 to 2030 (USD Million)
    • 5.3.4. Medical Writing
      • 5.3.4.1. Medical Writing Market, 2018 to 2030 (USD Million)
    • 5.3.5. Clinical Monitoring
      • 5.3.5.1. Clinical Monitoring Market, 2018 to 2030 (USD Million)
    • 5.3.6. Quality Management/ Assurance
      • 5.3.6.1. Quality Management/ Assurance Market, 2018 to 2030 (USD Million)
    • 5.3.7. Bio-statistics
      • 5.3.7.1. Bio-statistics Market, 2018 to 2030 (USD Million)
    • 5.3.8. Investigator Payments
      • 5.3.8.1. Investigator Payments Market, 2018 to 2030 (USD Million)
    • 5.3.9. Laboratory
      • 5.3.9.1. Laboratory Market, 2018 to 2030 (USD Million)
    • 5.3.10. Patient and site Recruitment
      • 5.3.10.1. Patient and site Recruitment Market, 2018 to 2030 (USD Million)
    • 5.3.11. Laboratory
      • 5.3.11.1. Laboratory Market, 2018 to 2030 (USD Million)
    • 5.3.12. Technology
      • 5.3.12.1. Technology Market, 2018 to 2030 (USD Million)
    • 5.3.13. Others
      • 5.3.13.1. Others Market, 2018 to 2030 (USD Million)

Chapter 6. Dermatology CRO Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2022 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. North America
    • 6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory Framework
      • 6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory Framework
      • 6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 6.6.2. India
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 6.7.2. Mexico
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
    • 6.7.5. Chile
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory Framework
      • 6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 6.8.3. UAE
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 6.8.4. Israel
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Israel Market Estimates and Forecasts, 2018 - 2030
    • 6.8.5. Iran
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Iran Market Estimates and Forecasts, 2018 - 2030
    • 6.8.6. Kuwait
      • 6.8.6.1. Key Country Dynamics
      • 6.8.6.2. Competitive Scenario
      • 6.8.6.3. Regulatory Framework
      • 6.8.6.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
    • 7.1.1. Innovators
    • 7.1.2. Market Leaders
    • 7.1.3. Emerging Players
    • 7.1.4. Company Market Share Analysis, 2022
  • 7.2. Company Profiles
    • 7.2.1. IQVIA, Inc.
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Labcorp Drug Development
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Aragen Life Sciences Ltd
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Service Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Service Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Parexel International Corporation
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Service Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Charles River Laboratories
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Service Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Icon, Plc
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Service Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Medidata
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Service Benchmarking
      • 7.2.8.4. Strategic Initiatives.
    • 7.2.9. Syneos Health
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Service Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. S Pharmaron
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Service Benchmarking
      • 7.2.10.4. Strategic Initiatives
    • 7.2.11. Wuxi Apptec
      • 7.2.11.1. Company Overview
      • 7.2.11.2. Financial Performance
      • 7.2.11.3. Service Benchmarking
      • 7.2.11.4. Strategic Initiatives
    • 7.2.12. Medpace
      • 7.2.12.1. Company Overview
      • 7.2.12.2. Financial Performance
      • 7.2.12.3. Service Benchmarking
      • 7.2.12.4. Strategic Initiatives
      • 7.2.12.5. CTI Clinical Trial & Consulting
    • 7.2.13. CTI Clinical Trial & Consulting
      • 7.2.13.1. Company Overview
      • 7.2.13.2. Financial Performance
      • 7.2.13.3. Service Benchmarking
      • 7.2.13.4. Strategic Initiatives
    • 7.2.14. Bioskin
      • 7.2.14.1. Company Overview
      • 7.2.14.2. Financial Performance
      • 7.2.14.3. Service Benchmarking
      • 7.2.14.4. Strategic Initiatives
    • 7.2.15. Proinnovera GmbH
      • 7.2.15.1. Company Overview
      • 7.2.15.2. Financial Performance
      • 7.2.15.3. Service Benchmarking
      • 7.2.15.4. Strategic Initiatives
    • 7.2.16. Biorasi, LLC
      • 7.2.16.1. Company Overview
      • 7.2.16.2. Financial Performance
      • 7.2.16.3. Service Benchmarking
      • 7.2.16.4. Strategic Initiatives
    • 7.2.17. Javara
      • 7.2.17.1. Company Overview
      • 7.2.17.2. Financial Performance
      • 7.2.17.3. Service Benchmarking
      • 7.2.17.4. Strategic Initiatives
    • 7.2.18. TFS
      • 7.2.18.1. Company Overview
      • 7.2.18.2. Financial Performance
      • 7.2.18.3. Service Benchmarking
      • 7.2.18.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 North America Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 Canada Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 10 Europe Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 11 Europe Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 12 Europe Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 13 UK Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 UK Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 15 Germany Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Germany Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 17 France Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 France Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 19 Italy Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 Italy Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 21 Spain Dermatology CRO Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 22 Spain Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 23 Denmark Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Denmark Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 25 Sweden Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Sweden Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 27 Norway Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Norway Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 32 China Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 China Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 34 Japan Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Japan Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 36 India Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 37 India Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 38 Australia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Australia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 South Korea Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 42 Thailand Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Thailand Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 44 Latin America Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 45 Latin America Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 46 Latin America Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 47 Brazil Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Brazil Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 49 Mexico Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Mexico Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 51 Argentina Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Argentina Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 53 Colombia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Colombia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 55 Chile Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 Chile Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 57 Middle East And Africa Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 58 Middle East And Africa Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 Middle East And Africa Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 South Africa Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 64 UAE Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 UAE Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 66 Iran Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 Iran Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 68 Israel Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Israel Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Dermatology CRO market outlook, 2018 - 2030
  • Fig. 9 Market trends & outlook
  • Fig. 10 Penetration & growth prospect mapping by service, 2022
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 SWOT Analysis, By factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 16 Global dermatology CRO market: Type movement analysis
  • Fig. 17 Drug discovery market 2018 - 2030 (USD Million)
  • Fig. 18 Target validation market 2018 - 2030 (USD Million)
  • Fig. 19 Lead identification market 2018 - 2030 (USD Million)
  • Fig. 20 Lead optimization market 2018 - 2030 (USD Million)
  • Fig. 21 Preclinical market 2018 - 2030 (USD Million)
  • Fig. 22 Clinical market 2018 - 2030 (USD Million)
  • Fig. 23 Phase I market 2018 - 2030 (USD Million)
  • Fig. 24 Phase II market 2018 - 2030 (USD Million)
  • Fig. 25 Phase III market 2018 - 2030 (USD Million)
  • Fig. 26 Phase IV market 2018 - 2030 (USD Million)
  • Fig. 27 Global dermatology CRO market: Service Type movement analysis
  • Fig. 28 Project management/clinical supply management market 2018 - 2030 (USD Million)
  • Fig. 29 Data management market 2018 - 2030 (USD Million)
  • Fig. 30 Regulatory/medical affairs market 2018 - 2030 (USD Million)
  • Fig. 31 Medical writing market 2018 - 2030 (USD Million)
  • Fig. 32 Clinical monitoring market 2018 - 2030 (USD Million)
  • Fig. 33 Quality management/ assurance market 2018 - 2030 (USD Million)
  • Fig. 34 Bio-statistics market 2018 - 2030 (USD Million)
  • Fig. 35 Investigator payments market 2018 - 2030 (USD Million)
  • Fig. 36 Laboratory market 2018 - 2030 (USD Million)
  • Fig. 37 Patient and site recruitment market 2018 - 2030 (USD Million)
  • Fig. 38 Technology market 2018 - 2030 (USD Million)
  • Fig. 39 Others market 2018 - 2030 (USD Million)
  • Fig. 40 Regional market place: Key takeaway
  • Fig. 41 Dermatology CRO regional outlook, 2022 & 2030
  • Fig. 42 North America dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 47 France dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 48 UK dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 55 China dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 57 India dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 62 Mexico dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 64 Colombia dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 65 Chile dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East & Africa Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 69 UAE Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 70 Israel Arabia Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 71 Iran Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait Dermatology CRO Market, 2018 - 2030 (USD Million)